Literature DB >> 34168246

An urgent need for improving thalassemia care due to the wide gap in current real-life practice and clinical practice guidelines.

Supachai Ekwattanakit1, Chattree Hantaweepant2, Archrob Khuhapinant2, Noppadol Siritanaratkul2, Vip Viprakasit3,4.   

Abstract

Based on Thalassemia International Federation clinical practice guidelines (CPG) for non-transfusion dependent and transfusion dependent thalassemia, several measures should be routinely implemented such as monitoring and surveillance of thalassemia related complications for early detection and proper clinical management. To evaluate the prevalence and the performance of routine surveillance for thalassemia related complications during 2 periods; before and after published CPGs (2012-2014 vs 2015-2017), data from 524 adult thalassemia patients attended at Siriraj hospital were compared among different treating physician groups; thalassemia, private hematology, and internal medicine clinics. Three most common complications were osteopenia/osteoporosis (69.8%), gallstones (67.6%) and abnormal vitamin D level (67.6%). Iron overload has been widely evaluated (93.1%) followed by liver function test (82.3%). However, the rate of evaluation for other complications were significantly reduced and < 25% of patients were evaluated in several complications. Comparing among clinics, the surveillance rate has increased significantly for several endocrine complications only in patients treated at thalassemia clinic but not in others. This study was the first study that evaluated real-world practical management of thalassemia patient in terms of complication surveillance. This different clinical practice has called for an immediate policy change to improve and standardize a care for thalassemia patients in Thailand.

Entities:  

Year:  2021        PMID: 34168246     DOI: 10.1038/s41598-021-92715-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  6 in total

1.  The influence of treatment in specialized centers on survival of patients with thalassemia major.

Authors:  Gian Luca Forni; Matteo Puntoni; Elio Boeri; Laura Terenzani; Manuela Balocco
Journal:  Am J Hematol       Date:  2009-05       Impact factor: 10.047

2.  Early development of decreased β-cell insulin secretion in children and adolescents with hemoglobin H disease and its relationship with levels of anemia.

Authors:  Pairunyar Nakavachara; Worarat Kajchamaporn; Julaporn Pooliam; Vip Viprakasit
Journal:  Pediatr Blood Cancer       Date:  2019-12-25       Impact factor: 3.167

3.  A prospective analysis for prevalence of complications in Thai nontransfusion-dependent Hb E/β-thalassemia and α-thalassemia (Hb H disease).

Authors:  Supachai Ekwattanakit; Noppadol Siritanaratkul; Vip Viprakasit
Journal:  Am J Hematol       Date:  2018-02-14       Impact factor: 10.047

4.  Inherited haemoglobin disorders: an increasing global health problem.

Authors:  D J Weatherall; J B Clegg
Journal:  Bull World Health Organ       Date:  2001-10-24       Impact factor: 9.408

5.  Children with hemoglobin E/β-thalassemia have a high risk of being vitamin D deficient even if they get abundant sun exposure: a study from Thailand.

Authors:  Pairunyar Nakavachara; Vip Viprakasit
Journal:  Pediatr Blood Cancer       Date:  2013-06-03       Impact factor: 3.167

Review 6.  The definition and epidemiology of non-transfusion-dependent thalassemia.

Authors:  David J Weatherall
Journal:  Blood Rev       Date:  2012-04       Impact factor: 8.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.